The role of a second transurethral resection for high-grade bladder cancer

Current Urology Reports

Volumn 1, Issue 3, 2000, Pages 204-207

  Langenstroer, Peter ^a   See, William ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bladder Cancer; Bladder Tumor; Muscularis Propria; Transitional Cell Carcinoma; Transurethral Resection

Indexed keywords

BLADDER TUMOR; CANCER STAGING; HUMAN; PATHOLOGY; REOPERATION; REVIEW;

HUMANS; NEOPLASM STAGING; REOPERATION; URINARY BLADDER NEOPLASMS;

EID: 0034309136     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-000-0020-6     Document Type: Article

References (20)

1. Herr H, Jakse G: pT1 bladder cancer. Eur Urol 1991, 20:1–8.
2. Heney NM, Ahmed S, Flanagan MJ, et al.: Superficial bladder cancer: progression and recurrence. J Urol 1983, 130:1083–1086.
3. Herr HW: Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome [see comments]. J Urol 2000, 163:60–61. A succinct article on the progression and recurrence rates of low-stage high-grade superficial bladder cancer. DOI: 10.1016/S0022-5347(05)67972-4
4. Mulders PF, Hoekstra WJ, Heybroek RP, et al.: Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group [see comments]. Eur J Cancer 1994, 30A:914–917. DOI: 10.1016/0959-8049(94)90113-9
5. Kaubisch S, Lum BL, Reese J, et al.: Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991, 146:28–31.
6. Herr HW: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999, 162:74–76. DOI: 10.1097/00005392-199907000-00018
7. Wijkstrom H, Norming U, Lagerkvist M, et al.: Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol 1998, 81:686–691. This article illustrates the need for a repeat transurethral resection as well as a bimanual examination prior to aggressive therapy for bladder cancer.
8. Kakizoe T, Tobisu K, Takai K, et al.: Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 1988, 48:2299–2303.
9. Kolozsy Z: Histopathological “self control” in transurethral resection of bladder tumours. Br J Urol 1991, 67:162–164. DOI: 10.1111/j.1464-410X.1991.tb15100.x
10. Klan R, Loy V, Huland H: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991, 146:316–318.
11. Mersdorf A, Brauers A, Wolff JM, et al.: Second TUR for superficial bladder cancer: a must [abstract]? J Urol 1998, 159:143.
12. Wolf H, Iversen HG, Rosenkilde P, Schroder T: Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2). Scand J Urol Nephrol Suppl 1987, 104:127–132.
13. Thrasher JB, Frazier HA, Robertson JE, Paulson DF: Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? [see comments]. J Urol 1994, 152:393–396.
14. Solsona E, Iborra I, Ricos JV, et al.: Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: prospective study. J Urol 1992, 147:1513–1515.
15. Solsona E, Iborra I, Ricos JV, et al.: Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study. J Urol 1998, 159:95–98. DOI: 10.1016/S0022-5347(01)64022-9
16. Herr HW: Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 1987, 138:1162–1163.
17. Gohji K, Nomi M, Okamoto M, et al.: Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 1999, 53:308–313. DOI: 10.1016/S0090-4295(98)00480-4
18. Kondas J, Vaczi L, Szecso L, Konder G: Transurethral resection for muscle-invasive bladder cancer. Int Urol Nephrol 1993, 25:557–563.
19. Mydlo JH, Weinstein R, Shah S, et al.: Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol 1999, 161:1128–1132. This article evaluates the concern for bladder perforation following TURBT and how this may impact disease progression. DOI: 10.1016/S0022-5347(01)61608-2
20. Bartholin P: Carcinoma implant in the abdominal wall after transurethral resection of bladder tumors using suprapubic trocar. A report of three cases. Scand J Nephrol 1995, 172(suppl):43.